Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
246.27
-2.89 (-1.16%)
Jan 17, 2025, 4:00 PM EST - Market closed
Alnylam Pharmaceuticals Analyst Ratings
Total Analysts
24
Consensus Rating
Buy
Price Target
$299.09
Upside
+21.45%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +62.42% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $320 | Strong Buy | Reiterates | $320 | +29.94% | Jan 13, 2025 |
| Bernstein | Bernstein | Buy Maintains $314 → $310 | Buy | Maintains | $314 → $310 | +25.88% | Jan 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $296 | Buy | Reiterates | $296 | +20.19% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +62.42% | Nov 18, 2024 |
| Wolfe Research | Wolfe Research | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +62.42% | Nov 4, 2024 |
| Raymond James | Raymond James | Buy Maintains $275 → $298 | Buy | Maintains | $275 → $298 | +21.01% | Nov 1, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $300 | Buy | Reiterates | $300 | +21.82% | Nov 1, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $305 → $310 | Buy | Maintains | $305 → $310 | +25.88% | Nov 1, 2024 |
| Barclays | Barclays | Buy Maintains $295 → $329 | Buy | Maintains | $295 → $329 | +33.59% | Nov 1, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $366 → $384 | Strong Buy | Maintains | $366 → $384 | +55.93% | Nov 1, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $300 | Strong Buy | Maintains | $300 | +21.82% | Nov 1, 2024 |
| Needham | Needham | Strong Buy Reiterates $320 | Strong Buy | Reiterates | $320 | +29.94% | Nov 1, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $282 → $371 | Strong Buy | Maintains | $282 → $371 | +50.65% | Oct 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $400 | Strong Buy | Reiterates | $400 | +62.42% | Oct 18, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.